4D11: The second mouse?

American Journal of Transplantation

Volumn 9, Issue 8, 2009, Pages 1701-1702

  Kirk, A D ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; EFALIZUMAB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HU5C8; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; EDITORIAL; GRAFT REJECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; SIGNAL TRANSDUCTION;

EID: 67650932380     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02749.x     Document Type: Editorial

References (6)

1. Kirk AD, Blair PJ, Tadaki DK, Xu H, Harlan DM. The role of CD154 in organ transplant rejection and acceptance. Philos Trans R Soc Lond B Biol Sci 2001 356 : 691 702.
2. Aoyagi T, Yamashita K, Suzuki T et al. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in Cynomolgus monkeys: Induction and maintenance therapy. Am J Transplant 2009 XX XX.
3. Lakkis FG, Sayegh MH. Memory T cells: A hurdle to immunologic tolerance. J Am Soc Nephrol 2003 14 : 2402 2410.
4. Adams AB, Pearson TC, Larsen CP. Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003 196 : 147 160.
5. Marie I, Maurey G, Hervé F, Hellot MF, Levesque H. Intravenous immunoglobulin-associated arterial and venous thrombosis: Report of a series and review of the literature. Br J Dermatol 2006 155 : 714 721.
6. Available from : http://www.fda.gov/medwAtch/safety/2009/safety09. htm#Raptiva. Accessed May 12, 2009.